Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company''s lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
最新股票文章
中国的经济危机比想象中还严重？
中国经济正面临严重困境，而这张图说明了原因。图中显示的是中国的房地产投资、新开工项目和房屋销售情况。可以看到，这三项指标在2021年年中达到峰值后大幅下滑。
15:45, 27 七月 2025
迈克尔·伯里为何清仓所有股票
迈克尔·伯里（Michael Burry）刚刚抛售了价值超过7000万美元的股票，清仓了整个投资组合，仅保留了一只股票，并加码投资一家其他投资者纷纷撤出的公司。伯里是极少数在2008年金融危机前成功预见市场崩溃的投资者之一，他做空房地产市场，一举赚取了7亿美元。
18:01, 22 七月 2025
评分与评论
评分与评论
